Catalyst Wire Dossier Catalyst Wire Dossier

Dexmedetomidine hydrochloride (generic)

dexmedetomidine hydrochloride · Fresenius Kabi USA, LLC
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Dexmedetomidine hydrochloride (generic), covering 2024-05-28 to 2024-05-28. Get the full timeline:

Most recent: FDA Approved: DEXMEDETOMIDINE HYDROCHLORIDE — Supplemental Application (Fresenius Kabi USA, LLC)

See pricing